CompletedNCT02566057
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 15 Years to 64 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT00621777
This study exists to understand how the medication Varenicline holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Varenicline can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Bipolarity
CompletedNCT00458094
This study exists to explore whether a guided support group could improve care and understanding. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Schizophrenia
CompletedNCT02308956
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 25 Years
- Countries
- Ethiopia
- Sponsor
- University of Cape Town
- Condition
- Schizophrenia
CompletedNCT01410357
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Case Western Reserve University
- Condition
- Schizophrenia
CompletedNCT01998516
This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Austria
- Sponsor
- Medical University Innsbruck
- Condition
- Bipolarity
CompletedNCT02304432
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 34 Years to 62 Years
- Countries
- Global
- Sponsor
- Mclean Hospital
- Condition
- Schizophrenia
CompletedNCT01720316
This study exists to understand how blood tests and biological markers holds up over time after the earliest research stage. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Schizophrenia
CompletedNCT01075295
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 14 Years to 45 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
CompletedNCT00833976
This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia
CompletedNCT03197168
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Chile
- Sponsor
- University of Chile
- Condition
- Schizophrenia
CompletedNCT01804257
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Proteus Digital Health, Inc.
- Condition
- Schizophrenia
CompletedNCT01731119
This study exists to see whether the medication Lurasidone is workable and worth testing more broadly. Researchers are trying to understand whether the medication Lurasidone can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 6 Years to 19 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
CompletedNCT00178958
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Northwestern University
- Condition
- Schizophrenia
CompletedNCT01244854
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand how people respond to questionnaires and follow-up reports in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Depression
CompletedNCT02212041
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT03152032
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- TsaoTun Psychiatric Center, Department of Health, Taiwan
- Condition
- Schizophrenia
CompletedNCT00167310
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
CompletedNCT01133587
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Norway
- Sponsor
- St. Olavs Hospital
- Condition
- Schizophrenia
CompletedNCT00184418
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOther
- Countries
- Norway
- Sponsor
- Norwegian University of Science and Technology
- Condition
- Schizophrenia
CompletedNCT03075800
This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 23 Years to 69 Years
- Countries
- Global
- Sponsor
- University of Washington
- Condition
- Schizophrenia
CompletedNCT01567943
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Depression
CompletedNCT01385709
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
- Condition
- Depression
CompletedNCT01786239
This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 15 Years to 40 Years
- Countries
- United States
- Sponsor
- Delbert Robinson
- Condition
- Schizophrenia
CompletedNCT02476877
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Advanced Clinical Laboratory Solutions, Inc.
- Condition
- Schizophrenia